Institutional rigor.
Built for
builders.
Vadis Advisory was built on a conviction: the financial expertise that shapes decisions at the highest levels of capital markets should be accessible to every ambitious company—not just the ones large enough to afford a full finance team.
Finance experience built at the highest levels—applied where it matters most.
Our team's background spans senior roles at leading financial institutions, where we directed complex strategic finance engagements for growth-stage and venture-backed companies across enterprise valuation, capital structure analysis, and board-level financial planning. That work was complemented by direct experience inside the investment process itself—underwriting credit and equity investments, preparing Investment Committee memoranda, and managing multi-million dollar portfolios within institutional fund environments.
At Vadis, we apply that institutional rigor directly to the founders and leadership teams we serve: building investor-readiness frameworks for early-stage companies, developing integrated financial models for companies approaching a capital raise, and serving as diligence partners for investors evaluating opportunities. We bring the same analytical discipline and precision that sophisticated investors expect—on behalf of the companies trying to earn their confidence.
Not a report-and-leave firm.
We embed, not consult.
We don't hand off decks and disappear. We operate as genuine members of your leadership team—present for the hard conversations, accountable for the outcomes, and invested in what happens after our work is done.
We turn the model into the decision.
Analysis is only worth something when it changes a decision. We turn modeling, scenarios, and capital structure work into a recommendation founders and boards can act on.
We bring the other side's perspective.
Our team has worked inside the investment process—underwriting deals, evaluating companies, and presenting to investment committees. That experience shapes how we help clients think about positioning, narrative, and diligence readiness.
Full-spectrum
financial partnership.
Forecasts & Operating Model
A forecast built on the drivers that actually move a deep tech business: unit cost, lead times, and compute per customer, not just headcount. An integrated model, scenarios you can run before the board asks, and one runway number everyone agrees on.
Includes
- — Integrated three-statement model
- — Driver-based forecast: unit cost, lead times, compute
- — Scenario & sensitivity analysis
- — Unit economics & pricing, including compute cost-to-serve
- — Runway & raise timing
Capital Strategy
Hardware capex is the most expensive capital a company spends, and equity is the most expensive way to pay for it. We plan capex and how to finance it, sequence equity, debt, and grants, and model dilution before terms are on the table.
Includes
- — Capex planning & equipment financing
- — Equity, debt & grant sequencing
- — Non-dilutive capital roadmap
- — Dilution & cap table modeling
- — Capital structure analysis
Fundraising & Investor Relations
We build the projections and diligence materials before the raise, then keep your board and investors on a steady cadence after it, so the next round is a scheduling problem rather than a fire drill.
Includes
- — Investor-readiness assessment
- — Projections & pitch deck financials
- — Diligence support & term sheet review
- — Board meeting preparation & materials
- — Quarterly investor updates
Finance Systems & Automation
The layer underneath: clean books, a fast close, and automations that feed the model directly, with the controls and audit trail that investors and federal auditors expect. Built to run without us.
Includes
- — Accounting & close oversight
- — Financial systems selection & implementation
- — Reporting automation & live dashboards
- — Controls, audit trail & grant compliance
- — KPI framework design
Results that speak
for themselves.
Architecting investor-readiness for an early-stage biotech from the ground up.
Delivered integrated financial projections, operating model, and board materials that positioned the company for its first institutional venture raise.
Early-Stage Biotech
Structuring a complex $50M exit scenario for a growth-stage technology company.
Built waterfall analysis and deal structure modeling that optimized shareholder return outcomes ahead of the liquidity event.
Growth-Stage Tech Company
Building institutional-grade investment frameworks for a VC firm's portfolio evaluation.
Standardized underwriting, sensitivity analysis, and screening processes—strengthening capital deployment discipline across the portfolio.
Venture Capital Firm